Immunic, inc. to announce financial results for the first quarter ended march 31, 2022 and provide corporate update

– webcast to be held at 8:00 am et on may 10, 2022 – new york, may 3, 2022 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced that the company will release its financial results for the first quarter ended march 31, 2022, including a corporate update, on tuesday, may 10, 2022, before the opening of the u.s. financial markets. a webcast will follow at 8:00 am et.
IMUX Ratings Summary
IMUX Quant Ranking